Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Trofinetide bulk supplier for pharma manufacturers

Trofinetide 200 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Oral Solution

Available Strengths: 200 mg/mL

Reference Brands: Daybue (USA)

Category: Orphan Drugs

Trofinetide is a synthetic analog of the naturally occurring tripeptide glycine-proline-glutamate (GPE) that is used for treating Rett syndrome in patients aged 2 years and older. It is taken orally as a solution twice daily, and aims to improve neurological function by supporting synaptic maturation and reducing neuroinflammation. It represents one of the first therapies approved specifically for Rett syndrome.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Trofinetide — third party manufacturing & bulk supply

Trofinetide 200 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Trofinetide is supplied as Oral Solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Trofinetide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Trofinetide →
Back to Listing

Frequently Asked Questions

Trofinetide is listed as Oral Solution in 200 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Trofinetide is referenced against Daybue (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Carglumic Acid

Strength:
200mg

Form: Dispersible Tablets

Reference Brands: Carbaglu (USA/EU)

View Details
Taliglucerase Alfa

Strength:
200U

Form: Injection

Reference Brands: Elelyso (USA/EU)

View Details
Agalsidase Beta

Strength:
35 mg

Form: Injection

Reference Brands: Fabrazyme (USA/EU)

View Details
Migalastat Hydrochloride

Strength:
123 mg

Form: Capsules

Reference Brands: Galafold (USA/EU)

View Details
Vutrisiran

Strength:
25mg/0.5ml

Form: Injection

Reference Brands: Amvuttra (USA/EU)

View Details
Emapalumab-Lzsg

Strength:
10 mg/2 mL, 50 mg/10 mL

Form: Injection

Reference Brands: Gamifant (USA/EU)

View Details
Doxecitine + Doxribtimine

Strength:
2g+2g

Form: Oral Solution

Reference Brands: Kygevvi (USA)

View Details
Arimoclomol

Strength:
47 mg, 62mg, 93mg

Form: Capsules

Reference Brands: MIPLYFFA (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.